Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Royce Investment Partners, commonly known as The Royce Funds, is a specialized investment management firm focused on small-cap and micro-cap equities. Founded in 1972 by Charles M. Royce, the firm is considered a pioneer in small-cap value investing, emphasizing companies with strong balance sheets and high returns on invested capital. While the firm is a financial services provider rather than a life sciences company, it actively invests in healthcare and biotechnology firms through its diverse range of mutual funds. Royce operates as an independent investment unit under the umbrella of its parent company, Franklin Templeton. The firm is headquartered in New York City and manages assets for both individual and institutional investors globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Royce Funds.